Zoetis Keeps Growing, but Headwinds Persist
It was much of the same for Zoetis (NYSE: ZTS) in the second quarter of 2019. The planet's leading animal health company grew revenue, maintained a healthy gross margin, and reported earnings growth after adjustments. The business even continued its tradition of acquisitions and investing in long-term research and development projects.
That said, the first half wasn't without a few warts. Zoetis continued to wade through weakness in its livestock segment, which weighed heavily on revenue and earnings growth. Seven of 11 international markets reported flat or negative growth compared to the year-ago period. American cats and dogs were responsible for nearly all of the company's growth in the first six months of 2019.
Should investors be worried? Here's what you need to know about Zoetis' latest operating results.
Quelle Fool.com
